Steve Harr Net Worth & Insider Trades

Steve Harr - CFO & Head, Juno Therapeutics, Inc

As of March 7, 2018

What is Steve Harr's Net Worth?

The current estimated net worth of Juno Therapeutics, Inc's CFO & Head, Steve Harr, is estimated to be about $99.75M . Steve Harr owns about 763,332 units of Juno Therapeutics, Inc common stock. In the last 3 years at Juno Therapeutics, Inc, Steve Harr has sold an estimated value of $52.53M worth.

What is Steve Harr's Past Insider Trading?

Steve Harr's largest purchase order was 8,750 units , worth over $76.3K on December 22, 2017. Steve Harr's largest sale order was 35,000 units , worth over $1.63M on December 11, 2015. In total, Steve Harr has made about 15 transactions over 3 years of their time at Juno Therapeutics, Inc. Steve Harr usually trades in March, with the busiest year in 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Steve Harr's' Mailing Address?

  • Mailing address is 307 Westlake Ave. North, Ste. 300 Seattle WA 98109 WA

What are Juno Therapeutics, Inc's Past Insider Trades?

Juno Therapeutics, Inc's most recent insider trade came on February 14, 2018 by Robert Azelby who sold 4,157 units worth $355.63K . In the last 3 years, insiders at Juno Therapeutics, Inc have sold an estimated value of $1.97B and bought an estimated value of $11.52M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Richard Klausner, Director,  Anthony Evnin, Director,  and Bernard Cassidy, General Counsel & Secretary .

Juno Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1